Genetics & Tissue Engineering of Heart Valve. Dieser Artikel ist nicht verfügbar.Genetics & Tissue Engineering of Heart Valve

The incidence and prevalence of heart valve disease is increasing worldwide and the number of heart valve replacements is expected to increase significantly in the future. By mimicking the main tissue structures and properties of human heart value, tissue engineering offers new options for the replacements. Applying an appropriate scaffold in fabricating tissue engineered heart valves (TEHVs) is of importance since it affects the secretion of the main extracellular matrix (ECM) components, collagen 1 and elastin, which are crucial for providing the mechanical, elastic and tensile strength of TEHVs. The VICs-encapsulated composite scaffold was observed to be more inductive to ECM secretion over the PGS-PCL-only and hydrogel-only scaffolds. This composite scaffold can serve as a three-dimensional structure model for heart valve tissue engineering with the capability of providing the necessary mechanical-properties such as, elasticity and tensile strength and the ability to grow, repair and be remodelled as a tissue.

Dr. Eslami graduated with M.D, PhD degrees. She has joined in Harvard Medical School as a part of her PhD dissertation in the field of Heart valve. She has received the title of "Best 2008 Women inventor" from WIPO and 6 Gold Medals and 6 Honorary Diplomas for her medical research and has published books and papers in these fields.